Hip replacement issues
March 25, 2013
IN addition to improving life
quality and diminishing pain, total
hip replacement (THR) is associated
with reduced mortality, heart
failure, depression and diabetes
rates in patients with osteoarthritis,
according to a new study presented
at the 2013 Annual Meeting of the
American Academy of Orthopaedic
Surgeons.
The study looked at more than
43,000 patients with osteoarthritis
of the hip from 1998 to 2009,
dividing them into two groups,
those receiving THR and those not
receiving THR.
The researchers then followed all
of the patients for at least one year,
and nearly 24,000 for seven years,
looking at annual US Medicare
payments, mortality, and new
diagnoses of congestive heart
failure, ischemic heart disease,
artherosclerosis (hardening and
narrowing of the arteries), diabetes
and depression.
According to the results, the THR
patients had a consistently lower
mortality risk – less than 52% of
that in the non-THR group; whilst
heart failure was similar between
groups in the first year, but there
was a consistent reduced risk (risk
was between.85 and .92 of the risk
for the non-THR group) at 3-to-7
years following surgery.
In addition, THR patients had a
reduced risk of diabetes at one and
three years and they also had a
reduced rate of depression starting
at three years post THR surgery.
The above article was sent to subscribers in Pharmacy Daily's issue from 25 Mar 13To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 25 Mar 13
